جست‌وجوی استاد و پژوهشگر

Derek Mark McKayمشاهده پروفایل

استاد

• Intestinal Physiology
• Gastrointestinal Immunology
• Inflammatory Bowel Disease (IBD)
• +۷ مورد دیگر

Derek Mark McKay is a Professor at the Cumming School of Medicine , University of Calgary , and holds the Lloyd Sutherland Professorship in IBD/GI Research . He directs the Snyder Institute for Chronic Diseases and is a full member of several academic networks, including the Inflammation Research Network and Gastrointestinal Research Group . Educational Background: BSc in Zoology, Queen's University of Belfast (1987) PhD in Zoology, Queen's University of Belfast (1990) His research focuses on intestinal physiology and immunity in health and disease , particularly: (1) the role of microbiota, immune mediators, and mitochondria in regulating epithelial barrier function, and (2) using helminth-rodent models to study immunomodulation pathways. His work is supported by major funders like CIHR , NSERC , Crohn’s Colitis Canada , and the Helmsley Charitable Trust . Scientific Awards: Honorary Doctor of Medicine, Linkoping University, Sweden (2022) Crohn's and Colitis Canada's Finkelstein Award (2021) Fellow, Canadian Academy of Health Sciences (2020) Canada Research Chair (Tier 1) (2006-2020) Fellow, American Association of Physiology (2020) C.P. Read Mentorship Award, American Society for Parasitology (2020) Fellow, Canadian Association of Gastroenterology (2016) Research Excellence Award, Canadian Association of Gastroenterology (2009) Stoll-Stunkard Memorial Lecture (2008) McKay has supervised 38 undergraduate students, 12 M.Sc., 11 Ph.D., and 15 post-doctoral fellows , including current advisees like Vickie Li (PhD candidate) and Armaan Mohan (PhD student). His lab includes key members like Arthur Wang (Lab Manager).

Masmudur Rahmanمشاهده پروفایل

استادیار

• Molecular Virology
• Cancer Biology
• Oncolytic Viruses
• +۳ مورد دیگر

Masmudur Rahman is an Assistant Professor at Arizona State University (ASU), affiliated with the School of Life Sciences and the Biodesign Center for Personalized Diagnostics. He leads research on molecular virology, focusing on oncolytic viruses like myxoma virus (MYXV) to treat cancers, particularly leveraging their ability to target cancer cells with compromised innate immunity. His work combines virology, genetic engineering, microscopy, and bioinformatics. Education highlights include a BSc and MSc from the University of Dhaka, a PhD in Molecular Virology from the Indian Institute of Science (IISc), and postdoctoral research at the University of Western Ontario and University of Florida, studying poxvirus immune modulation. He has received grants from NIH and the Arizona Biomedical Research Commission for projects on cancer virotherapy and virus-host interactions. Research interests span viral host range mechanisms, tumor tropism, and combination therapies (e.g., selinexor + MYXV). His lab develops strategies to enhance viral efficacy using stem cells and explores autosis induction in CAR-T cells. He teaches undergraduate research and honors courses in microbiology and cell biology, emphasizing hands-on training in virology techniques. Grants include NIH-funded studies on overcoming CAR-T resistance via autosis and targeting metastatic cancers with MYXV-selinexor combinations. His work has been published in Viruses , Cancer Research Communications , and International Journal of Molecular Sciences , among others.

Barbara N. Timmermannمشاهده پروفایل

استاد

• Natural Products Chemistry
• Drug Discovery from Biodiversity
• Botanical Dietary Supplements
• +۴ مورد دیگر

Barbara N. Timmermann is the Interim Dean and University Distinguished Professor at the University of Kansas School of Pharmacy, Department of Medicinal Chemistry. She holds a PhD in Botany from the University of Texas and has over 40 years of research experience in natural products chemistry, drug discovery, and pharmacognosy. Education PhD in Botany (Phytochemistry), University of Texas at Austin MA in Botany (Phytochemistry), University of Texas at Austin BSc in Biological Sciences, Universidad Nacional de Córdoba, Argentina Research Focus Botanical dietary supplements (turmeric/ginger for inflammation) Biodiversity drug discovery (ICBG Program) Withanolide anti-cancer mechanisms OATP transporter interactions Chemotaxonomy and plant secondary metabolites Awards & Recognition AAAS and ASP Fellowships NIH-funded Center Directorships (COBRE, ICBG) Women's Hall of Fame (University of Kansas) Regents Professor (University of Arizona) Leadership Former Chair of Medicinal Chemistry (2005-2012) Completed Senior Administrative Fellow Program (2010-2011) Directed NIH-funded core laboratories Labs & Collaborations COBRE Center for Cancer Experimental Therapeutics Arizona Center for Phytomedicine Research International Biodiversity Research Programs

Stephen Renaudمشاهده پروفایل

دانشیار

• Placental Development
• Reproductive Biology
• Cellular and Molecular Mechanisms
• +۳ مورد دیگر

Dr. Stephen Renaud is an Associate Professor in the Department of Anatomy and Cell Biology at Western University. He holds a PhD and B.Sc. from Queen's University. His research focuses on placental development and function, particularly the cellular and molecular mechanisms underlying trophoblast differentiation and maternal-fetal immune interactions. Key interests include OVO-like transcription factors, endogenous retroviral genes, and maternal immune tolerance. His work bridges basic science with public health implications, addressing complications like pre-eclampsia and fetal growth restriction. Publications emphasize placental biology, immunology, and developmental mechanisms, with contributions to journals like Placenta , Proceedings of the National Academy of Sciences , and Cellular and Molecular Life Sciences . No scientific awards are listed, but his research has been widely cited (h-index 28). He advises no listed students but maintains an active lab exploring placental biology. His office is in the Medical Sciences Building, Room 428, with contact via srenaud4@uwo.ca.

Virginia Pedicordمشاهده پروفایل

استادیار

• Immunology
• Microbiota
• Host-Pathogen Interaction
• +۴ مورد دیگر

Dr. Virginia Pedicord is a Principal Investigator at the University of Cambridge's Department of Medicine and the Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID). She leads the Pedicord Lab within the Cambridge Immunology Network as a Sir Henry Dale Fellow, a prestigious research fellowship jointly funded by the Royal Society and Wellcome Trust. Her research focuses on understanding the complex interactions between gut microbiota, host immunity, and disease pathogenesis. Dr. Pedicord received her PhD in Immunology and Microbial Pathogenesis from Cornell University under the supervision of Dr. James P. Allison at Memorial Sloan Kettering Cancer Center, where she studied CD8+ T cell biology. She completed her postdoctoral training at the Rockefeller University before joining the University of Cambridge in 2018. Her laboratory employs a multi-disciplinary approach combining functional metagenomics, in vivo models, cellular immunology, transcriptomics, and proteomics to investigate how commensal microbes influence host intestinal and systemic physiology. Research focuses on gut microbiota's role in immune responses and pathogen resistance Investigates how gut microbes and microbial metabolites affect resistance to infection Studies local and systemic T cell responses and gut-brain axis of neuronal function Uses functional metagenomics to identify cellular and molecular targets of microbiota-mediated immunity Dr. Pedicord's recent publications demonstrate a strong focus on how specific gut bacteria like Enterocloster clostridioformis protect against pathogens such as Salmonella, how microbial metabolites enhance cancer immunotherapy, and the role of the microbiome in various disease contexts including pancreatic cancer and inflammatory bowel disease. Her work bridges fundamental microbiome research with potential therapeutic applications. Scientific Recognition: Sir Henry Dale Fellow (2018) Dr. Pedicord's research program aims to provide mechanistic insights into host-microbiota interactions that will advance our understanding of infectious diseases, autoimmune disorders, and cancer, potentially enabling new therapeutic approaches. Her laboratory is situated at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus.

Andrew Z. Wangمشاهده پروفایل

استاد

• Cancer Research
• Nanotechnology
• Biomedical Engineering
• +۲ مورد دیگر

Andrew Z. Wang, M.D., is a tenured Professor and holds the A. Kenneth Pye Professorship in Cancer Research at the University of Texas Southwestern. He serves as Vice Chair for Translational Research and Commercialization in the Department of Radiation Oncology, having joined UTSW in August 2021. Previously, he held faculty positions at the University of North Carolina, where he rose from Assistant to Tenured Professor. Dr. Wang's research integrates biomedical engineering with oncology to develop innovative cancer diagnostics and therapeutics. His work focuses on: Nanotechnology-enabled drug delivery systems Cancer immunotherapy and vaccine development Biomaterial applications in oncology Liquid biopsy technologies for treatment monitoring Radiotherapy-enhancing strategies His 128+ publications demonstrate consistent focus on translational nanomedicine, with recent works advancing combination therapies (chemoradiation-immunotherapy), 3D-printed medical devices, and machine learning applications in oncology. Clinical publications emphasize optimizing radiation techniques for genitourinary/gastrointestinal cancers. Major scientific recognitions include: Fellow of the American Association for the Advancement of Science (AAAS) Fellow of the American Institute for Medical and Biological Engineering (AIMBE) Fellow of the American Society for Clinical Investigation (ASCI) A. Kenneth Pye Professorship in Cancer Research Dr. Wang leads a prolific research program generating 38 patents and founding three biotechnology startups. Clinically, he specializes in advanced radiation techniques (IMRT, SBRT, brachytherapy) for genitourinary and gastrointestinal malignancies.

• Innate Immunity
• Inflammation
• IBD (Inflammatory Bowel Disease)
• +۶ مورد دیگر

Averil Ma, MD is a Professor of Medicine at the University of California, San Francisco (UCSF) School of Medicine. He serves as Director of the UCSF IBD Center and Chief of the Division of Gastroenterology. His research focuses on molecular and cellular mechanisms underlying inflammation and cancer, particularly studying ubiquitin-regulating proteins like A20. He holds notable roles such as Chair of the NIH CMI-A Study Section (2010-2012) and Founding Chair of the KRF Scientific Advisory Board (2009). Education: A.B. in Biochemistry from Harvard College (1980), M.D. from Columbia University (1984), Internal Medicine residency at Massachusetts General Hospital (1987), and Gastroenterology fellowship at Columbia (1989). Research interests include host-commensal interactions in the gut, innate immunity, and ubiquitin-dependent immune regulation. His lab investigates A20’s role in preventing inflammation and cancer via NF-κB signaling, inflammasome control, and tissue integrity. Techniques used include CRISPR, mass spectrometry, and mouse models. Key awards include election to the American Society for Clinical Investigation (2001) and AGA/GRG Young Investigator Award (2001). Publications focus on A20’s functions in inflammation, cancer, and autoimmune diseases, with contributions to understanding ubiquitin pathways and therapeutic targets for IBD, psoriasis, and SLE.

Pedro Ferreiraمشاهده پروفایل

استاد

• Business Model Innovation
• Cultural Management
• Digital Display Systems
• +۳ مورد دیگر

Pedro Ferreira is a Professor at Iscte Business School, ISCTE - IUL, Lisbon, Portugal. His academic work spans multiple disciplines including business model innovation, cultural management, digital display systems, and consumer behavior. Key research areas: Business Model Innovation, Cultural Management, Digital Display Systems Interdisciplinary work: Healthcare Management, Energy Efficiency, Sensory Marketing Notable collaborations: Rock in Rio, Ferreira's de Castro Cultural Complex His publications demonstrate ecosystem-based approaches to cultural economics, with applications in virtual reality exhibitions and sustainable business practices. Recent work focuses on technology integration in perfume exhibitions and energy efficiency strategies. Earlier research includes pharmacological studies on P2X7 receptors in colitis and foundational financial accounting textbooks. He has analyzed group buying systems in Portugal and explored intersections between management theory and art. Academic contributions span 45 years, with a 2024 patent on digital display systems and a 1979 report on tomato industry economics. Current affiliations include: Iscte Business School ExecED at ISCTE INDEG-ISCTE Edifício INDEG-ISCTE, Lisbon

• Biophotonics
• Nanotechnology
• Fluorescence Applications
• +۷ مورد دیگر

Professor Ewa Goldys is a distinguished academic at the University of New South Wales (UNSW), serving as a Professor in the School of Engineering with a focus on Biomedical Engineering. She holds the prestigious position of Deputy Director at the ARC Centre of Excellence for Nanoscale Biophotonics (CNBP), where she leads partnerships, knowledge transfer, and research commercialization efforts. Her work spans interdisciplinary research connecting engineering, medicine, and biology, with significant contributions to biophotonics and nanotechnology applications in healthcare. Professor Goldys' research interests center around advanced imaging techniques, particularly autofluorescence characterization, which provides a non-invasive metabolic 'fingerprint' for distinguishing healthy from diseased cells. Her work has significant applications in cancer, diabetes, and neurodegenerative diseases. She has pioneered research in fluorescent and luminescent nanomaterials for biological applications, developing innovative approaches for high-contrast, background-free imaging using time-gating techniques. Her research portfolio also includes significant contributions to CRISPR-based biosensing, stem cell characterization, and non-invasive diagnostic approaches using multispectral imaging. Her publication record demonstrates a clear trend toward increasingly sophisticated applications of autofluorescence imaging combined with machine learning and molecular techniques. Recent work integrates hyperspectral imaging with transcriptomics, develops CRISPR-based point-of-care diagnostics, and applies autofluorescence techniques to diverse medical challenges from kidney disease diagnosis to immune cell characterization. The interdisciplinary nature of her work spans oncology, immunology, nephrology, and regenerative medicine. Professor Goldys has received notable recognition for her work, including: Eureka award in 2016 for Innovative Use of Technology Her research leadership has secured substantial funding, including directing the $23 million ARC investment in the CNBP (matched by $17 million from partners), establishing the $2 million ARC/NHMRC Network 'Fluorescence Applications in Biotechnology and Life Sciences,' and leading research that leveraged an additional $155 million in external funding. She has founded the Optical Characterisation Facility at Macquarie University and has been instrumental in establishing international research networks in biophotonics. Professor Goldys has made significant contributions to the international biophotonics community through conference organization, having chaired 11 conferences including SPIE 'Biophotonics Australasia' and serving as Track Chair for Nanobiophotonics at BIOS, the world's largest biomedical optics meeting. Her work has established foundational methodologies in autofluorescence characterization that continue to drive innovation in label-free medical diagnostics.

Margaret Alexanderمشاهده پروفایل

استادیار

• Microbiome-Immune Interactions
• Autoimmunity
• Diet-Microbiota-Immune Axis
• +۳ مورد دیگر

Dr. Margaret Alexander is an Assistant Professor in the Department of Medical Microbiology and Immunology at the University of Wisconsin-Madison, where she leads a research laboratory focused on the interactions between diet, the gut microbiota, and the immune system in autoimmune diseases. She began her independent career at UW-Madison in January 2024 after completing postdoctoral training at UCSF. Her educational background includes: B.S. in Biology from Carleton College Ph.D. from the University of Utah under Dr. Ryan O'Connell, studying immune cell communication Postdoctoral work at UCSF with Dr. Peter Turnbaugh on microbiota-immune interactions in autoimmunity Dr. Alexander's research centers on decoding mechanistic interactions between diet, microbiota, and immune responses using mouse models, gnotobiotics, anaerobic microbiology, and sequencing . Her lab investigates how dietary components shape microbial metabolism and immune function, with particular focus on Th17 cell regulation, microbial enzyme activity, and metabolite-mediated host responses in conditions like inflammatory bowel disease and rheumatoid arthritis. This work bridges fundamental microbiology with translational applications for autoimmune disease treatment. Analysis of her recent publications reveals three dominant trends: (1) Identification of specific microbial metabolites (e.g., lactate, polyphenol derivatives) that modulate immune pathways; (2) Development of precision tools for microbiome manipulation including phage-delivered CRISPR; and (3) Investigation of dietary interventions (ketogenic diets, prebiotics) as therapeutic strategies. Her work consistently connects microbial metabolic capabilities to host immune outcomes in autoimmunity. Her scientific contributions have been recognized through prestigious awards: T32 fellowship F32 fellowship K99/R00 career development award Dr. Alexander mentors a diverse research team using a philosophy emphasizing collaboration, creativity, and clear communication . She currently advises two Ph.D. students (Wenxuan Dong and Gillian Hughes) and supervises postdoctoral scholars, with structured mentoring through weekly 1:1 meetings and annual planning sessions. Her lab has secured significant grant funding including NIH K99/R00 support for her diet-microbiome-immune axis research. The Alexander Lab operates within the Microbial Sciences Building at UW-Madison as a dynamic interdisciplinary team comprising postdoctoral scholars, graduate students, a research specialist, and undergraduate researchers. They employ integrated approaches spanning microbial ecology, immunology, and systems biology to unravel complex host-microbe-diet interactions, with ongoing projects focused on microbial enzyme characterization, therapeutic dietary strategies, and microbiome-based biomarkers for autoimmune disease progression.

Thea Tlstyمشاهده پروفایل

استاد

• Epithelial-stromal interactions
• Genomic instability
• Chronic inflammation and cancer
• +۳ مورد دیگر

Dr. Thea Tlsty is a Professor at the University of California San Francisco (UCSF) School of Medicine, Department of Pathology. With over 25 years of experience in cancer biology, she leads multidisciplinary research on epithelial-stromal interactions, chronic inflammation, and cellular plasticity in carcinogenesis. Her lab developed the first biomarkers for ductal carcinoma in situ risk stratification and discovered rare pluripotent cells in normal tissues with implications for metaplastic cancers. Education: BS in Zoology (University of South Florida, 1973) PhD in Molecular Biology (Washington University, 1980) Predoctoral Fellow (Washington University, 1976-1980) Postdoctoral Fellow & Senior Research Associate (Stanford University, 1981-1985) Dr. Tlsty's research focuses on: Stromal-epithelial stress response mechanisms Chronic inflammation's role in cancer CD36 repression in high mammographic density Pluripotent cell biology Multi-investigator grant projects Her 15 most recent publications highlight trends in proteomics, spatial transcriptomics, and multi-omics integration to study tumor microenvironment dynamics, particularly in breast, esophageal, and colorectal cancers. Scientific Awards: Cancer Research UK Grand Challenge Grant (£20M) NCI Outstanding Investigator Award Blaffer Distinguished Lectures (MD Anderson) Nakahara Award (Princess Takamatsu Foundation) KOMEN Scholar & AVON Scholar Elected AAAS Fellow NCI Knudson Award Dr. Tlsty has received continuous NIH funding since 1987, including ongoing R35 grant (R35CA197694) for studying stress-associated cellular plasticity. Her lab's translational insights bridge basic discoveries with clinical applications for cancer prevention and therapy.

Sunil Thomasمشاهده پروفایل

استاد پژوهشی

• Translational Research
• Vaccine Development
• Immunotherapy
• +۶ مورد دیگر

Sunil Thomas, PhD , is a Research Professor at the Lankenau Institute for Medical Research (LIMR), with a distinguished career in translational science. His work bridges microbiology, immunology, molecular biology, and cell biology to develop diagnostic tools and vaccines for diseases affecting millions globally. He has held academic titles at LIMR since 2012, including Research Assistant Professor, Research Associate Professor, and now Research Professor. Current roles: Research Professor (2022–Present), Editor of Vaccine Design: Methods and Protocols (Springer-Nature), and Visiting Professor at Temple University (2017). Education: BSc in Botany (Kerala University), MSc in Biotechnology (Cochin University of Science and Technology), PhD in Environmental Biotechnology (Cochin University), and Postdoctoral Fellowship at Mount Sinai School of Medicine. Research interests encompass translational studies on immunotherapies for ulcerative colitis and Alzheimer’s disease, focusing on Bin1 monoclonal antibodies. He has pioneered structure-based vaccines for ehrlichiosis, modeled SARS-CoV-2 membrane proteins, and developed diagnostic tools like the ELISA kit for T-cell lipid rafts and Eastern Blotting for post-translational modifications. His lab investigates antibody uptake mechanisms and gut-brain axis interactions using animal models. Recent publications highlight his work on viral protein structure (Camp Hill, Borealpox, Oropouche), microbiome analysis in ICUs, diet-immunotherapy interactions, and advancements in AI-driven vaccine design. He has also contributed to understanding SARS-CoV-2 pathogenesis, monoclonal antibody therapies, and microbiome-host health connections. Patents include methods for disease treatment, Ehrlichia diagnostics, biosimulator technology, heat shock protein peptides, and vaccines against ehrlichiosis. Commercialized products like the IDO1 monoclonal antibody are now diagnostic probes in cancer research.

• Virology
• Infectious Diseases
• Zoonotic Diseases
• +۵ مورد دیگر

Susan Compton is a Senior Research Scientist in Comparative Medicine at Yale University's Yale School of Medicine, where she also serves as Director of Molecular and Serological Diagnostics. Her research focuses on viral infections in rodents, including coronaviruses, parvoviruses, and zoonotic pathogens. She holds a PhD from the Uniformed Services University (1988) and a BS in Biology from Bucknell University (1981). Compton's work emphasizes diagnostic methodologies, viral transmission dynamics, and the development of animal models for infectious diseases. Notable contributions include studies on SARS-CoV-2 transmission modeling using rat coronaviruses and investigations into mucormycosis in immunodeficient rodents. She has authored over 25 peer-reviewed publications and holds awards such as the Pravin N. Bhatt Scientific Investigator Award (2019). Her lab, the Virology Diagnostic Lab, contributes to health monitoring of laboratory animals and pathogen detection. Compton collaborates with researchers like Caroline Zeiss and Brent Vander Wyk on projects addressing viral zoonoses and pandemic-to-endemic disease transitions.

• Mathematical oncology
• Cancer evolution
• Multiscale modeling
• +۴ مورد دیگر

Dr. Kathleen Curtius is an Assistant Professor in the Department of Medicine at the University of California San Diego (UCSD), affiliated with the Division of Biomedical Informatics and the UCSD Moores Cancer Center. She leads the Quantitative Cancer Control laboratory, focusing on early cancer detection and prevention through mathematical modeling and multi-scale data analysis. Previously, she held a Medical Research Council Rutherford Fellowship at Barts Cancer Institute (London) and completed postdoctoral training in Prof. Trevor Graham's lab. Her research integrates applied mathematics, computational biology, and clinical oncology to address cancer evolution and screening strategies. Education: PhD in Applied Mathematics, University of Washington (2015) MS in Applied Mathematics, University of Washington (2011) BS in Mathematics, UCLA (2010) Research Interests: Mathematical oncology Cancer evolution modeling Epigenetic drift analysis Screening optimization Multiscale tumor dynamics Her work bridges disciplines to develop predictive tools for early cancer detection and personalized surveillance strategies. Publications: Recent work includes studies on metagenomic data bias (Nature Communications 2025), AI-driven cancer biomarker discovery (JCI Insight 2022), and computational models of Barrett's esophagus progression (Gut 2020). Her research emphasizes translational applications in clinical oncology and public health. Awards: Recognized with the 2024 Leah Edelstein-Keshet Prize, 2022 AGA Research Scholar Award, and 2018 MRC Rutherford Fellowship. Her work has been cited over 1,000 times across key oncology journals. Funding: Principal Investigator on NIH grants (R01CA270235, I01BX005958) supporting projects on Barrett's esophagus modeling and colitis-associated colorectal cancer surveillance optimization. Collaborates with clinicians, geneticists, and computational biologists to advance cancer control efforts. Labs/Teams: Leads the Quantitative Cancer Control Lab at UCSD, part of the Bioinformatics and Systems Biology division. Active in interdisciplinary initiatives like the Moores Cancer Center's Cancer Control Program.

Arthur Kaserمشاهده پروفایل

استاد

• Inflammatory Bowel Disease (IBD)
• Gastroenterology
• Immunology
• +۵ مورد دیگر

Professor Arthur Kaser is a leading academic gastroenterologist and Professor of Gastroenterology at the University of Cambridge. He leads the Gastrointestinal Diseases theme of the NIHR Cambridge Biomedical Research Centre, a partnership between Cambridge University Hospitals and the University of Cambridge. Department of Medicine Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) British Society for Immunology Funding Recipient His groundbreaking research focuses on the mechanisms of Inflammatory Bowel Disease (IBD) , including: Dysregulation of enterocyte cell intrinsic processes causing IBD Genetic polymorphisms linked to disease risk Purine nucleoside metabolism and unfolded protein response Mitochondrial metabolism in immune regulation Role of GPR35 and ORMDL proteins in epithelial homeostasis Recent publications highlight his work across genetic models, metabolic pathways, and clinical trials in IBD, with a focus on: AAV8 gene therapy for mitochondrial disorders ER stress and autophagy in intestinal epithelium Anti-IL-23 therapies (mirikizumab, risankizumab) Polyunsaturated fatty acids in Crohn's disease pathogenesis Scientific honors include: Fellow of the Academy of Medical Sciences (FMedSci) Fellow of the Royal Society (FRS) He collaborates with clinicians and researchers including Dr. James Lee, Dr. Nicole Kaneider, Dr. Trevor Lawley , and Professor Gordon Dougan. His work is supported by the Medical Research Council and institutional grants from the NIHR Cambridge Biomedical Research Centre.